Loading company
Loading
Latest quarter · Q3 FY2025
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (1)
Zivo Bioscience, Inc. (ZIVO) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $157,220 | $27,650 | +468.6% | 10-K 2025-03-18 · proof |
| Gross profit | $48,952 | $11,610 | +321.6% | 10-K 2025-03-18 · proof |
| Operating income | -$13.4 million | -$7.3 million | 10-K 2025-03-18 · proof | |
| Net income | -$13.4 million | -$7.8 million | 10-K 2025-03-18 · proof | |
| Cash from operating activities | -$4.3 million | -$5.8 million | 10-K 2025-03-18 · proof | |
| Total assets | $1.6 million | $555,715 | +195.7% | 10-K 2025-03-18 · proof |
| Total liabilities | $2.2 million | $2.8 million | -21.9% | 10-K 2025-03-18 · proof |
| Cash and cash equivalents | $1.5 million | $274,380 | +462.2% | 10-K 2025-03-18 · proof |
- What was Zivo Bioscience, Inc. (ZIVO)'s revenue in fiscal 2024?
- Zivo Bioscience, Inc. (ZIVO) reported revenue of $157,220 for fiscal 2024 (the year ended Dec 31, 2024), against $27,650 the year before (+468.6%). Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
- What was Zivo Bioscience, Inc. (ZIVO)'s gross profit in fiscal 2024?
- Zivo Bioscience, Inc. (ZIVO) reported gross profit of $48,952 for fiscal 2024 (the year ended Dec 31, 2024), against $11,610 the year before (+321.6%). Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
- What was Zivo Bioscience, Inc. (ZIVO)'s operating income in fiscal 2024?
- Zivo Bioscience, Inc. (ZIVO) reported operating income of -$13.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$7.3 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
- What was Zivo Bioscience, Inc. (ZIVO)'s net income in fiscal 2024?
- Zivo Bioscience, Inc. (ZIVO) reported net income of -$13.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$7.8 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
- What was Zivo Bioscience, Inc. (ZIVO)'s cash from operating activities in fiscal 2024?
- Zivo Bioscience, Inc. (ZIVO) reported cash from operating activities of -$4.3 million for fiscal 2024 (the year ended Dec 31, 2024), against -$5.8 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
- What are Zivo Bioscience, Inc. (ZIVO)'s total assets?
- As of Dec 31, 2024, Zivo Bioscience, Inc. (ZIVO) reported total assets of $1.6 million, against $555,715 a year earlier (+195.7%). Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
- What are Zivo Bioscience, Inc. (ZIVO)'s total liabilities?
- As of Dec 31, 2024, Zivo Bioscience, Inc. (ZIVO) reported total liabilities of $2.2 million, against $2.8 million a year earlier (-21.9%). Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
- What are Zivo Bioscience, Inc. (ZIVO)'s cash and cash equivalents?
- As of Dec 31, 2024, Zivo Bioscience, Inc. (ZIVO) reported cash and cash equivalents of $1.5 million, against $274,380 a year earlier (+462.2%). Source: the 10-K filed with the SEC on Mar 18, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ZIVO&period_type=annual&limit=5"Information only, not investment advice.